Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization

Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization

Anti-VEGF agents were found to have clinical implications for the successful treatment of vascular-driven diseases in humans. In this study, a detailed biological characterization of bevacizumab in a variety of in vitro assays was carried out to determine the effect of bevacizumab on equine umbilica...

Full description

Bibliographic Details
Main Authors:	Ulrike Lessiak, Barbara Pratscher, Alexander Tichy, Barbara Nell
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Veterinary Sciences
Subjects:	anti-VEGF equine umbilical vein endothelial cells bevacizumab angiogenesis
Online Access:	https://www.mdpi.com/2306-7381/10/11/632

Similar Items

Expression of vascular endothelial growth factor (VEGF) in equine sarcoid
by: Manuela Martano, et al.
Published: (2018-09-01)

The Effect of Microgravity Condition on Expression of VEGFR-2 Gene in Human Umbilical Vein Endothelial Cells (HUVEC)
by: Homa Dadgarnia, et al.
Published: (2016-05-01)

Antiangiogenic effect of pinobanksin on human umbilical vein endothelial cells
by: Ho-Jeong Bang, et al.
Published: (2021-04-01)

Enhancement of radiation response with bevacizumab
by: Hoang Tien, et al.
Published: (2012-04-01)

A comparison of peroxisome proliferator-activated receptor-α agonist and antagonist on human umbilical vein endothelial cells angiogenesis
by: Nasim Dana, et al.
Published: (2013-01-01)

Teucrium polium Extract Enhances the Anti-Angiogenesis Effect of Tranilast on Human Umbilical Vein Endothelial Cells
by: Fatemeh Sheikhbahaei, et al.
Published: (2018-03-01)

Suppressing VEGF-A/VEGFR-2 Signaling Contributes to the Anti-Angiogenic Effects of PPE8, a Novel Naphthoquinone-Based Compound
by: Ming-Jen Hsu, et al.
Published: (2022-07-01)

Citrus-derived auraptene stimulates angiogenesis by activating the Erk- and PI3K/Akt/eNOS-dependent signaling pathways in human umbilical vein endothelial cells
by: Shuaiyu Wang, et al.
Published: (2012-10-01)

Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities
by: Aysegül Tura, et al.
Published: (2019-06-01)

Apoptotic Extracellular Vesicles Derived from Human Umbilical Vein Endothelial Cells Promote Skin Repair by Enhancing Angiogenesis: From Death to Regeneration
by: Liu J, et al.
Published: (2024-01-01)

The Potential Influence of Residual or Recurrent Disease on Bevacizumab Treatment Efficacy in Ovarian Cancer: Current Evidence and Future Perspectives
by: Klaudia Żak, et al.
Published: (2024-03-01)

Profiles of Endoglin and Vascular Endothelial Growth Factor Based on Staging and Histological Grading of Colorectal Cancer and Their Relationship with Bevacizumab Therapy
by: Rahmawati Minhajat, et al.
Published: (2021-05-01)

Angiogenic Potential of VEGF Mimetic Peptides for the Biofunctionalization of Collagen/Hydroxyapatite Composites
by: Suya Wang, et al.
Published: (2021-10-01)

Polysialic acid is released by human umbilical vein endothelial cells (HUVEC) in vitro
by: Sebastian Strubl, et al.
Published: (2018-12-01)

Anti-Angiogenic Activity of Ficus carica Latex Extract on Human Umbilical Vein Endothelial Cells
by: Ali Mostafaie, et al.
Published: (2011-01-01)

The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
by: Domenico Ribatti, et al.
Published: (2021-07-01)

Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications
by: Liu J, et al.
Published: (2019-11-01)

The phytochemical screening and antiangiogenic activity of audthan al himar (Moricandia sinaica Boiss.) extracts in zebrafish embryos and human umbilical vein endothelial cells
by: Muhammad Farooq, et al.
Published: (2020-06-01)

Testing endodontic sealers on human umbilical vein endothelial cells
by: Moldovan Marioara, et al.
Published: (2013-08-01)

Targeting regulation of VEGF by BPTF in non-small cell lung cancer and its potential clinical significance
by: Meng Dai, et al.
Published: (2022-12-01)

Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells
by: Bin Huang, et al.
Published: (2013-07-01)

Animal study on transplantation of human umbilical vein endothelial cells for corneal endothelial decompensation
by: Li Cui, et al.
Published: (2014-06-01)

Dl-3-n-butylphthalide attenuates H2O2-induced oxidative damage of human umbilical vein and umbilical artery endothelial cells
by: YANG Xiao-li, WANG Zheng, ZHANG Yan-ru, JI Jing-jing, WANG Meng-shuai
Published: (2021-10-01)

Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer
by: Mohsin Hamid, et al.
Published: (2018-05-01)

Administration of Bevacizumab and the Risk of Chronic Kidney Disease Development in Taiwan Residents: A Population-Based Retrospective Cohort Study
by: Lon-Fye Lye, et al.
Published: (2023-12-01)

EDIL3 and VEGF Synergistically Affect Angiogenesis in Endothelial Cells
by: Niu X, et al.
Published: (2023-05-01)

Propofol attenuates hydrogenperoxide-induced apoptosis in human umbilical vein endothelial cells via multiple signaling pathways
by: Cheng Lan Xie, et al.
Published: (2015-10-01)

Comparison of conventional and directional freezing for the cryopreservation of human umbilical vein endothelial cells
by: Bing Qi, et al.
Published: (2014-10-01)

Soya-cerebroside inhibits VEGF-facilitated angiogenesis in endothelial progenitor cells
by: Hsiang-Ping Lee, et al.
Published: (2020-01-01)

Profiling of Differentially Expressed MicroRNAs in Human Umbilical Vein Endothelial Cells Exposed to Hyperglycemia via RNA Sequencing
by: Nur Syakirah Othman, et al.
Published: (2023-05-01)

Curcumin Attenuates Acrolein-induced COX-2 Expression and Prostaglandin Production in Human Umbilical Vein Endothelial Cells
by: Seung Eun Lee, et al.
Published: (2020-01-01)

Hyperoside Protects Human Umbilical Vein Endothelial Cells Against Anticardiolipin Antibody-Induced Injury by Activating Autophagy
by: Aiwu Wei, et al.
Published: (2020-05-01)

Platelet Lysate Inhibits NF-κB Activation and Induces Proliferation and an Alert State in Quiescent Human Umbilical Vein Endothelial Cells Retaining Their Differentiation Capability
by: Alessio Romaldini, et al.
Published: (2019-04-01)

Coral-Derived Compound WA-25 Inhibits Angiogenesis by Attenuating the VEGF/VEGFR2 Signaling Pathway
by: Shih-Wei Lin, et al.
Published: (2015-02-01)

Effects of gintonin on the proliferation, migration, and tube formation of human umbilical-vein endothelial cells: involvement of lysophosphatidic-acid receptors and vascular-endothelial-growth-factor signaling
by: Sung-Hee Hwang, et al.
Published: (2016-10-01)

Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells
by: Patrick R. Merz, et al.
Published: (2018-12-01)

VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
by: Saquib Naeem, et al.
Published: (2019-04-01)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
by: Laine I, et al.
Published: (2017-11-01)

<i>Glossogyne tenuifolia</i> Extract Increases Nitric Oxide Production in Human Umbilical Vein Endothelial Cells
by: Chin-Feng Hsuan, et al.
Published: (2021-06-01)

Induction of vascular endothelial growth factor receptor expression in human umbilical vein endothelial cells after repeated bevacizumab treatment in vitro
by: Ji Eun Lee, et al.
Published: (2017-07-01)